drugset
drugset / Trial / NCT01520545

Safety Study of 3 mg/mL Baclofen Injection (Intrathecal) Using A Programmable Pump

NCT01520545 ↗

Phase 3 Completed 153 enrolled Piramal Critical Care, Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Safety study to assess the 3 mg/mL baclofen injection (intrathecal) using a programmable pump

Timeline

Start
2012-12
Primary completion
2016-08
Completion
2016-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 3 mg/ml Intrathecal

Indications

No indication recorded.